Opinion: In Defense of Preprints
Opinion: In Defense of Preprints
In response to two November 2021 articles in The Scientist that called out preprints as a source of medical misinformation, the cofounders of bioRxiv and medRxiv say it’s not the publishing model that’s at fault.
In response to two November 2021 articles in The Scientist that called out preprints as a source of medical misinformation, the cofounders of bioRxiv and medRxiv say it’s not the publishing model that’s at fault.
medRxiv
Q&A: New Preprint Server for Clinical Research
Chia-Yi Hou | Jun 5, 2019 | 4 min read
The cofounder of bioRxiv, Richard Sever, discusses why there’s a need for the preprint server medRxiv that launched today.